Abstract:Aim: To explore the degradation characteristics of composite of calcium polyphosphate fiber (CPPF), calcium phosphate cement (CPC) and micromorselized bone in vitro. Methods: The experiment was conducted in the Central Laboratory of Animal Experiment of the First Hospital Affiliated to Harbin Medical University from February to October 2005. 1 The rabbit iliac bone was made into micromorselized bone with the diameter of 300-500 μm. 2 Two groups of biochemical composite were made respectively according to the mass-ratios of CPPF/CPC/micromorselized bone at 1:4:4 (CPPF group/CPC group/micromorselized bone group) and that of CPC/micromorselized bone at 1:1 (CPC group/micromorselized bone group). 3 The porosity was calculated by studying the pore diameter of composite under scanning electron microscope. 4 In vitro experiment of degradation, two groups of composite were put into the phosphate buffered solution (PBS) (pH 7.4) respectively to study the changes in weight-loss ratio of composite in degradation liquid as well as the changes in pH value of degradation liquid and the biomechanical changes in composite at different time-points. Results: 1 Changes in porosity, pH value and mass of degradation of both kinds of composites: The porosity of composite of CPPF/CPC/ micromorselized bone was 72.1% with the pore diameter of 100-400, and the pH value was constant while degradation. The mass changed little within 4 weeks and decreased rapidly after the 4th week, which was 50% of the initial mass in the 12th week. The porosity of compound materials of CPC/micromorselized bone was 58.2% and was 50-300 μm in the gap diameter with slight changes in pH value, and the mass changed little within 6 weeks, which decreased rapidly after 6 week, and was 70% of the initial mass in the 12th week. 2 Biomechanical changes in composite of two groups in the degradation: the primary biomechanical strength was 9.28 MPa in CPPF/CPC/micromorselized bone and was 6.21 MPa in CPC/ micromorselized bone, and there was significant difference between them (P< 0.05). The strength of CPPF/CPC/micromorselized bone decreased slowly within 4 weeks, then decreased obviously after 4 weeks, which was 0.18 MPa in the 12th week, while the strength of CPC/micromorselized bone decreased symmetrically and was 0.24 MPa in the 12th week. Conclusion: The composite of CPPF/CPC/micromorselized bone is a new bone repair material, which is suitable for bone tissue engineering for its good characteristics of porosity, pore diameter and degradation.

Magnesium Phosphate/PBS/Wheat Protein Biocomposite for Bone Repair

A Bioactive Degradable Composite Bone Cement Based on Calcium Sulfate and Magnesium Polyphosphate

A new composite fabricated from hydroxyapatite, gelatin-MgO microparticles, and compatibilized poly(butylene succinate) with osteogenic functionality

A novel strategy for calcium magnesium phosphate/carboxymethyl chitosan composite bone cements with enhanced physicochemical properties, excellent cytocompatibility and osteogenic differentiation

Construction of macroporous magnesium phosphate-based bone cement with sustained drug release

Influence of Monocalcium Phosphate on the Properties of Bioactive Magnesium Phosphate Bone Cement for Bone Regeneration

A Biodegradable Magnesium Phosphate Cement Incorporating Chitosan and Rhbmp-2 Designed for Bone Defect Repair

Carboxymethyl chitosan-alginate enhances bone repair effects of magnesium phosphate bone cement by activating the FAK-Wnt pathway

Study on the degradation of hydroxypropyl methylcellulose‐modified magnesium phosphate cement in different solutions

Novel, Degradable, and Cytoactive Bone Cements Based on Magnesium Polyphosphate and Calcium Citrate

Development of Magnesium Calcium Phosphate Biocement for Bone Regeneration

Degradation of bone repairing composite of calcium polyphosphate fiber, calcium phospate cement and micromorselized bone in vitro

Activity of cladribine combined with cyclophosphamide in frontline therapy for chronic lymphocytic leukemia with 17p13.1/TP53 deletion

Stimulation of erythropoiesis by cyclic adenosine monophosphate.

A Bioactive Gelatin-Methacrylate Incorporating Magnesium Phosphate Cement for Bone Regeneration

Bioactive Porous Biocomposites Coated Magnesium Alloy Implant for Bone Rejuvenation Using a Fracture in Rat Model

Microstructure, mechanical properties, in vitro degradation behavior and in vivo osteogenic activities of Zn-1Mg-β-TCP composites for bone defect repair

Incorporation of clay minerals into magnesium phosphate bone cement for enhancing mechanical strength and bioactivity

Novel injectable and self-setting composite materials for bone defect repair

Magnesium-Based Composite Calcium Phosphate Cement Promotes Osteogenesis and Angiogenesis for Minipig Vertebral Defect Regeneration

Composite scaffolds of dicalcium phosphate anhydrate /multi-(amino acid) copolymer: in vitro degradability and osteoblast biocompatibility